MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Abbott Laboratories

Fermé

SecteurSoins de santé

128.47 1.01

Résumé

Variation du prix de l'action

24h

Actuel

Min

128.47

Max

129.22

Chiffres clés

By Trading Economics

Revenu

454M

1.8B

Ventes

784M

11B

P/E

Moyenne du Secteur

16.484

36.442

BPA

1.26

Rendement du dividende

1.75

Marge bénéficiaire

15.967

Employés

114,000

EBITDA

383M

3B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+14.07% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.75%

3.00%

Date du Prochain Dividende

17 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1B

229B

Ouverture précédente

127.46

Clôture précédente

128.47

Sentiment de l'Actualité

By Acuity

57%

43%

296 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 oct. 2025, 12:02 UTC

Résultats

Abbott Labs Posts Higher 3Q Sales, Reaffirms Outlook

17 juil. 2025, 12:10 UTC

Résultats

Abbott Labs Pares Outlook, Logs 2Q Profit Gains

15 oct. 2025, 16:15 UTC

Résultats

Abbott Stock Drops Despite Earnings. Baby-Formula Sales Took a Hit. -- Barrons.com

15 oct. 2025, 12:25 UTC

Résultats

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway. -- Barrons.com

15 oct. 2025, 11:32 UTC

Résultats

Abbott Labs Still Sees 2025 Organic Sales Up 6%-7% Including Covid-19 Testing-Related Sales >ABT

15 oct. 2025, 11:32 UTC

Résultats

Abbott Labs Still Sees 2025 Organic Sales Up 7.5%-8% Excluding Covid-19 Testing-Related Sales >ABT

15 oct. 2025, 11:31 UTC

Résultats

Abbott Labs Sees 2025 Adj EPS $5.12-Adj EPS $5.18 >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q Adjusted Operating Margin 23% >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs Reaffirms Full-Year Guidance >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q Organic Sales Growth Up 5.5% >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q Sales $11.37B >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q Adj EPS $1.30 >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q Net $1.64B >ABT

15 oct. 2025, 11:30 UTC

Résultats

Abbott Labs 3Q EPS 94c >ABT

11 oct. 2025, 00:18 UTC

Acquisitions, Fusions, Rachats

Why Biotech May Be Back -- Barrons.com

17 juil. 2025, 13:14 UTC

Résultats

Abbott Labs Stock Falls After Earnings. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 juil. 2025, 12:16 UTC

Résultats

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 juil. 2025, 11:32 UTC

Résultats

Abbott Labs Sees 3Q Adj EPS $1.28-Adj EPS $1.32 >ABT

17 juil. 2025, 11:32 UTC

Résultats

Abbott Labs: See Momentum Carrying Into 2026 >ABT

17 juil. 2025, 11:31 UTC

Résultats

Abbott Labs Sees 2025 Organic Sales Up 7.5%-8%, Excluding Covid-19 Testing-Related Sales >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Organic Sales Rose 6.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adjusted Operating Margin 22.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adjusted Gross Margin 57% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Organic Sales Growth Up 6.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Sales $11.14B >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Net $1.78B >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adj EPS $1.26 >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs Sees FY Adj EPS $5.10-Adj EPS $5.20 >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q EPS $1.01 >ABT

17 juil. 2025, 09:08 UTC

Actions en Tendance

Stocks to Watch Thursday: TSMC, United Airlines, Sarepta -- WSJ

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

14.07% hausse

Prévisions sur 12 Mois

Moyen 146.63 USD  14.07%

Haut 162 USD

Bas 136 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

20 ratings

18

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

132.82 / 134.43Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Neutral Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

296 / 371Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat